Murine induced pluripotent stem cells (iPSCs) lacking IL-1 receptor type 1 (IL-1R1), engineered using the CRISPR/Cas9 system, are able to form cartilaginous tissue that is resistant to IL-1α-mediated inflammation, a new study shows.
To get content containing either thought or leadership enter:
To get content containing both thought and leadership enter:
To get content containing the expression thought leadership enter:
You can enter several keywords and you can refine them whenever you want. Our suggestion engine uses more signals but entering a few keywords here will rapidly give you great content to curate.
Murine induced pluripotent stem cells (iPSCs) lacking IL-1 receptor type 1 (IL-1R1), engineered using the CRISPR/Cas9 system, are able to form cartilaginous tissue that is resistant to IL-1α-mediated inflammation, a new study shows.